Journal of Autism and Developmental Disorders · 2021 · 32 citations · 8 references
EducationPediatricsPharmacotherapyAutism Spectrum DisordersBehavioral DisordersDevelopmental-behavioral PediatricsAttention-deficit/hyperactivity DisorderCo-occurring Medical ConditionsCo-occurring Mental Health ConditionsMental Health ComorbiditiesNeurodevelopmental DisordersTreatment Of Mental DisordersAdhd PrevalenceAdhd TreatmentAutism Spectrum Disorder InterventionCohort Study InvestigationCombination TherapyMood Disorder ComorbidityTherapy SwitchingTreatment Patterns Epidemiology
We used real world data to summarize comorbidities and interventions among patients newly diagnosed with autism spectrum disorder (ASD). Data were derived from two claims-based US healthcare databases; Medicaid and Optum to construct a retrospective cohort of 36,000 patients. Attention-Deficit-Hyperactivity-Disorder (ADHD) was the most common co-morbidity (Medicaid: 50.09%; Optum: 44.16%), followed by mood disorder (Medicaid: 16.56% and Optum: 17.47%). Most patients received at least one type of treatment. Behavioral therapy was common (74.64% in Medicaid and 71.97% in Optum). More than half the cohorts received at least 1 pharmacotherapy. However, pharmacotherapies were diverse. Combination therapy and therapy switching was common. Understanding the clinical diversity and complexity of patients with ASD is an important first step in understanding unmet therapeutic needs.
8
Prevalence of Autism Spectrum Disorder Among US Children and Adolescents, 2014-2016
Guifeng Xu, Lane Strathearn, Buyun Liu et al. · JAMA · 2018 · 344 citations · Full text
Does a claims diagnosis of autism mean a true case?
J. P. Burke, Anjali Jain, Wenya Yang et al. · Autism · 2013 · 121 citations
Medicine, Pediatrics, Psychiatry +17
Treatment patterns in children with autism in the United States
Brigitta U. Monz, Richard Houghton, Kiely Law et al. · Autism Research · 2019 · 92 citations · Full text